Kusuri No Aoki Holdings Co Ltd
TSE:3549
Kusuri No Aoki Holdings Co Ltd
TSE:3549
Price:
2 889.5 JPY
1.21%
Market Closed
Updated:
May 3, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
10.7
Current
11
Median
8.3
Industry
Lower
than median
Higher
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=10.7
Enterprise Value
/
305.1B
EBITDA
28.4B
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| JP |
|
Kusuri No Aoki Holdings Co Ltd
TSE:3549
|
273.3B JPY | 10.7 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
72.3B Zac | 0 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
28.2B Zac | 0 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
15.1B USD | 5.2 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
44B BRL | 12.7 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
44.2B CNY | 21.5 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
927.9B JPY | 9.1 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.9B SAR | 11.3 | |
| MX |
|
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
76.5B MXN | 7.8 | |
| JP |
|
Cosmos Pharmaceutical Corp
TSE:3349
|
582.5B JPY | 11.4 | |
| CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
24.7B CNY | 14.7 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
10.2
2-Years Forward
EV/EBITDA
7.9
3-Years Forward
EV/EBITDA
7.4
You don't have any saved screeners yet
